
    
      The study is a prospective, multi-center, randomized controlled pivotal clinical trial to
      evaluate the safety and effectiveness of the EVOQUE System with optimal medical therapy (OMT)
      compared to OMT alone in the treatment of patients with at least severe tricuspid
      regurgitation. Subjects will be followed at discharge, 30 days, 3 months, 6 months and
      annually through 5 years.
    
  